Pharmaceutical

FDA approves new administration routes for Xcopri 

SK Life Sciences Xcopri (cenobamate) is approved as an oral suspension mixed with water for mouth administration or via a nasogastric tube.

Apr 13, 2024 - 00:00
FDA approves new administration routes for Xcopri 
SK Life Sciences Xcopri (cenobamate) is approved as an oral suspension mixed with water for mouth administration or via a nasogastric tube.
Read the original article

Tags:

Previous Article

UK charities condemn continued drug shortages

Next Article

Candel wins FDA orphan drug designation for pancreatic cancer drug

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

A new study of sick infants sees potential in DNA sequencing, but also a need for better ways to interpret the genome

A new study of sick infants sees potential in DNA seque...

Jul 12, 2023

How COVID-19 M&A performed in the pharmaceutical indust...

Jul 27, 2023

Spark Therapeutics partners with SpliceBio for gene therapy

Spark Therapeutics partners with SpliceBio for gene the...

Oct 17, 2023